Relationship Between CT- Value With Prognosis in COVID-19 Patients

evaluate the relationship between cycle threshold number with final prognosis in COVID-19 patients

Completed

Looking for future studies?

Key information

Conditions

COVID-19 Coronaviridae Infections Coronavirus Infections Infections Lung Diseases Nidovirales Infections Pneumonia Pneumonia, Viral RNA Virus Infections Respiratory Tract Diseases Respiratory Tract Infections Virus Diseases

Sex eligibility

All sexes

Study type

Observational

Primary location

Nooshin Dalili, Tehran, Iran

About this study

evaluate the relationship between cycle threshold number with final prognosis in COVID-19 patients

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

COVID-19 PCR positive

Exclusion criteria

Treatment and study plan

Cycle threshold

Diagnostic Test

cycle threshold number

Primary outcomes

prognosis

Time frame: 6 months

death or alive

Sponsors and collaborators

Lead sponsor

Shahid Beheshti University of Medical Sciences

Other

Registry information

Important dates

Study start: 2021
Primary completion: 2022
Study completion: 2022
First posted: May 26, 2021
Registry last updated: Jul 18, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed